A 52-year-old woman with metastatic breast cancer presents to the pain clinic with severe, uncontrolled cancer pain despite adequate doses of oral morphine. Which is the most common reason for inadequate analgesia in this patient?

Explanation

## Most Common Cause of Inadequate Cancer Pain Control **Key Point:** Inadequate dosing or inappropriate dosing intervals are the most common reasons for treatment failure in cancer pain management, not true opioid tolerance or psychological factors. ### Why Dosing is the Primary Issue In clinical practice, the majority of patients with uncontrolled cancer pain have not received sufficient opioid doses at appropriate intervals. This is often due to: 1. **Physician-related factors**: Fear of opioid side effects, addiction concerns, or lack of knowledge about equianalgesic dosing 2. **Patient-related factors**: Reluctance to increase doses due to misconceptions about addiction 3. **Inadequate assessment**: Failure to use pain rating scales or reassess pain regularly ### Comparison with Other Causes | Cause | Frequency | Clinical Features | |-------|-----------|-------------------| | Inadequate dosing | Most common (>70%) | Pain relief with dose escalation | | True tolerance | Rare (<5%) | Requires escalating doses despite adequate pain control initially | | Psychological dependence | Uncommon in cancer | Behavioral signs; pain control may be secondary | | Malabsorption | Rare | GI symptoms; improved with alternative route | **High-Yield:** The WHO analgesic ladder recommends titrating opioid doses until pain is controlled or side effects become limiting — inadequate dosing is a failure of implementation, not a failure of the drug. **Clinical Pearl:** When a cancer patient reports inadequate pain relief, the first step is always to review the current opioid dose and frequency, not to assume tolerance or switch to a different agent. ### Management Approach 1. Assess current pain severity using numerical rating scale (NRS) or visual analog scale (VAS) 2. Calculate equianalgesic dose and increase by 25–50% if pain is moderate to severe 3. Adjust dosing interval to match pain duration (e.g., short-acting every 4 hours; long-acting every 12 hours) 4. Address breakthrough pain with short-acting formulations 5. Manage side effects (constipation, nausea) proactively **Warning:** Confusing inadequate dosing with tolerance leads to inappropriate drug switching and continued suffering. True opioid tolerance is rare in cancer patients when doses are properly titrated.